BRINKS CO 8-K

What Happened
Brink’s Co. (Brink’s) filed an 8‑K describing the planned two-step acquisition of NCR Atleos Corp. under a Merger Agreement dated February 26, 2026. The deal structure: Merger Sub I will merge into NCR Atleos (First Merger), then NCR Atleos will merge into Merger Sub II (Second Merger), leaving Merger Sub II as a Brink’s subsidiary. The joint registration statement on Form S‑4 was declared effective May 27, 2026, and both companies began mailing the joint proxy/prospectus that day. Special shareholder meetings are scheduled for June 30, 2026. After the announcement, two shareholder lawsuits were filed in New York Supreme Court (June 10 and June 11, 2026) challenging disclosures and seeking to enjoin the Mergers. To address disclosure claims and reduce litigation risk, Brink’s and NCR Atleos voluntarily supplemented the joint proxy/prospectus (without admitting liability); the Mergers’ terms and meeting timings remain unchanged and both boards continue to recommend voting “FOR” the proposals.

Key Details

• Merger structure: two-step merger via Novus Merger Sub, Inc. and Novus Merger Sub II, LLC; Merger Agreement dated Feb 26, 2026. Special meetings: June 30, 2026.
• Litigation: Two complaints (Connolly and Thompson) filed June 10–11, 2026 in NY Supreme Court alleging negligent misrepresentation and concealment; plaintiffs seek injunctions and fees.
• Supplemental disclosures amend proxy sections including background, financial advisor analyses and assumptions (examples: Morgan Stanley noted NCR Atleos net debt of $2,722M and Brink’s net debt of $2,743M in its DCFs; J.P. Morgan used net debt figures of $2,621M for NCR Atleos and $2,617M for Brink’s).
• Fees disclosed: NCR Atleos agreed to pay J.P. Morgan an estimated aggregate advisory fee of $43.0M (plus possible additional $7.0M) with $4.0M payable upon delivery of its opinion.

Why It Matters
This filing confirms the definitive merger process and that Brink’s and NCR Atleos are proactively supplementing proxy disclosure to address shareholder litigation risk. For investors, the key takeaways are: (1) the Merger terms and vote dates remain unchanged and both boards recommend approval; (2) pending lawsuits allege disclosure deficiencies and could, if successful, delay or block the transaction or increase costs; and (3) the filings disclose substantial net debt levels and advisor fees used in valuation work — factors that relate to financing, deal rationale and integration risk. Retail investors should review the supplemented joint proxy/prospectus and consider the litigation and financing-related risk factors before voting.